Global Blood Therapeutics, Inc.·4

Aug 14, 9:47 PM ET

Sham Hing 4

4 · Global Blood Therapeutics, Inc. · Filed Aug 14, 2017

Insider Transaction Report

Form 4
Period: 2017-08-11
Sham Hing
See Remarks
Transactions
  • Award

    Restricted Stock Units

    2017-08-11+12,00012,000 total
    Common Stock (12,000 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock.
  • [F2]The RSUs vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION